[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201411306D0 - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
GB201411306D0
GB201411306D0 GBGB1411306.2A GB201411306A GB201411306D0 GB 201411306 D0 GB201411306 D0 GB 201411306D0 GB 201411306 A GB201411306 A GB 201411306A GB 201411306 D0 GB201411306 D0 GB 201411306D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic composition
immunogenic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1411306.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1411306.2A priority Critical patent/GB201411306D0/en
Publication of GB201411306D0 publication Critical patent/GB201411306D0/en
Priority to CN201580039744.7A priority patent/CN106536544B/en
Priority to MX2016017094A priority patent/MX2016017094A/en
Priority to SI201530954T priority patent/SI3160500T1/en
Priority to BR112016030096-3A priority patent/BR112016030096B1/en
Priority to PT157334046T priority patent/PT3160500T/en
Priority to BE2015/5390A priority patent/BE1022949B1/en
Priority to EP19192151.9A priority patent/EP3636278A3/en
Priority to CA2952118A priority patent/CA2952118A1/en
Priority to EP15733404.6A priority patent/EP3160500B1/en
Priority to DK15733404T priority patent/DK3160500T3/en
Priority to LT15733404T priority patent/LT3160500T/en
Priority to PCT/EP2015/064324 priority patent/WO2015197737A1/en
Priority to HUE15733404A priority patent/HUE045936T2/en
Priority to US15/320,190 priority patent/US20170218031A1/en
Priority to PL15733404T priority patent/PL3160500T3/en
Priority to ES15733404T priority patent/ES2749701T3/en
Priority to JP2016575190A priority patent/JP6688233B2/en
Priority to CY20191101061T priority patent/CY1122145T1/en
Priority to HRP20191864TT priority patent/HRP20191864T1/en
Priority to JP2020005532A priority patent/JP2020100625A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
GBGB1411306.2A 2014-06-25 2014-06-25 Immunogenic composition Ceased GB201411306D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB1411306.2A GB201411306D0 (en) 2014-06-25 2014-06-25 Immunogenic composition
JP2016575190A JP6688233B2 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
DK15733404T DK3160500T3 (en) 2014-06-25 2015-06-25 CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION
PCT/EP2015/064324 WO2015197737A1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
SI201530954T SI3160500T1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
BR112016030096-3A BR112016030096B1 (en) 2014-06-25 2015-06-25 IMMUNOGENIC COMPOSITION, VACCINE, AND, USE OF AN IMMUNOGENIC COMPOSITION OR A VACCINE
PT157334046T PT3160500T (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
BE2015/5390A BE1022949B1 (en) 2014-06-25 2015-06-25 IMMUNOGENIC COMPOSITION
EP19192151.9A EP3636278A3 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
CA2952118A CA2952118A1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
EP15733404.6A EP3160500B1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
CN201580039744.7A CN106536544B (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic compositions
LT15733404T LT3160500T (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
MX2016017094A MX2016017094A (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition.
HUE15733404A HUE045936T2 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
US15/320,190 US20170218031A1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
PL15733404T PL3160500T3 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition
ES15733404T ES2749701T3 (en) 2014-06-25 2015-06-25 Immunogenic composition of Clostridium difficile
CY20191101061T CY1122145T1 (en) 2014-06-25 2019-10-09 IMMUNE COMPOSITION FOR CLOSTRIDIUM DIFFICILE
HRP20191864TT HRP20191864T1 (en) 2014-06-25 2019-10-15 Clostridium difficile immunogenic composition
JP2020005532A JP2020100625A (en) 2014-06-25 2020-01-17 Clostridium difficile immunogenic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1411306.2A GB201411306D0 (en) 2014-06-25 2014-06-25 Immunogenic composition

Publications (1)

Publication Number Publication Date
GB201411306D0 true GB201411306D0 (en) 2014-08-06

Family

ID=51410109

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1411306.2A Ceased GB201411306D0 (en) 2014-06-25 2014-06-25 Immunogenic composition

Country Status (1)

Country Link
GB (1) GB201411306D0 (en)

Similar Documents

Publication Publication Date Title
GB201610599D0 (en) Immunogenic Composition
IL248223B (en) Vaccine compositions
ZA201702401B (en) Composition with reduced immunogenicity
HK1218859A1 (en) Composition
HK1214967A1 (en) Composition
SG11201704735WA (en) Composition
GB201403017D0 (en) Composition
ZA201704464B (en) Composition
GB201614485D0 (en) Immunogenic composition
HK1244432A1 (en) Composition
GB201414910D0 (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
SG11201610547WA (en) Solid composition
GB201404700D0 (en) Novel Composition
IL250781A0 (en) Composition
GB201411371D0 (en) Immunogenic composition
GB201411306D0 (en) Immunogenic composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)